Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the osteoporosis drugs market?

The market size for osteoporosis drugs has been experiencing consistent growth over the years. The expansion from $12.33 billion in 2024 to $12.8 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 3.8%, indicates this steady growth. Factors contributing to this upward trend during the historical period include an aging populace, elevated levels of awareness and diagnosis, lifestyle influences, governmental actions, and health care policies.

What will be the osteoporosis drugs market size in the future?

Get your osteoporosis drugs market report here!

https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

What main drivers are fueling expansion in the osteoporosis drugs market?

The osteoporosis drug market’s expansion is anticipated to be fuelled by an increase in osteoporosis occurrences. Osteoporosis, a bone condition characterized by reduced bone mineral density and bone mass or alterations in bone quality, is more prevalent in individuals with lower calcium intake. Osteoporosis medications are beneficial as they boost bone mineral density and aid in preventing bone fractures. The Australian Institute of Health and Welfare Australia-Government agency reported that in 2022, osteoporosis was responsible for 2,659 deaths, an equivalent of 10.2 deaths per 100,000 population, consequently representing 1.4% of all deaths. This indicates that the escalating prevalence of osteoporosis is a key force propelling the growth of the osteoporosis drug market.

What key areas define the segmentation of the global osteoporosis drugs market?

The osteoporosis drugs market covered in this report is segmented –

1) By Type: Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors

2) By Administration: Oral, Injectable

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Sales

4) By Application: Primary Osteoporosis, Secondary Osteoporosis

Subsegments:

1) By Bisphosphonates: Alendronate, Risedronate, Ibandronate, Zoledronic Acid

2) By Selective Estrogen Receptor Modulators (SERMs): Raloxifene, Bazedoxifene

3) By RANK Ligand Inhibitors: Denosumab

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9102&type=smp

Who are the dominant players expanding their reach in the osteoporosis drugs market?

Major companies operating in the osteoporosis drugs market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck & Co Inc., Novartis AG, Bristol Myers Squibb Company, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Pharma Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd, Mylan N.V., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Ipsen, Kyowa Kirin Co Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Recordati S.p.A., Cadila Healthcare Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Sunovion Pharmaceuticals Inc., Theramex, Radius Health Inc., Strides Pharma Science Limited, Apotex Inc.

How are evolving market trends shaping osteoporosis drugs Strategies?

Pfizer Inc., F. Hoffmann La Roche Ltd., Merck & Co Inc., Novartis AG, Bristol Myers Squibb Company, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Pharma Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd, Mylan N.V., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Ipsen, Kyowa Kirin Co Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Recordati S.p.A., Cadila Healthcare Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Sunovion Pharmaceuticals Inc., Theramex, Radius Health Inc., Strides Pharma Science Limited, Apotex Inc. are amongst the prominent businesses in the osteoporosis drugs market.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9102

Which regions are emerging as leaders in the osteoporosis drugs market?

North America was the largest region in the osteoporosis market in 2024. The regions covered in the osteoporosis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Neurosurgery Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurosurgery-devices-and-equipment-global-market-report

Cardiovascular Surgery Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Cardiovascular Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: